Literature DB >> 22157171

An inverse and independent association between Helicobacter pylori infection and the incidence of shigellosis and other diarrheal diseases.

Dani Cohen1, Ofra Shoham, Nadav Orr, Khitam Muhsen.   

Abstract

OBJECTIVES: We examined the association between Helicobacter pylori infection and the incidence of diarrheal diseases.
METHODS: In a nested case-control study participants were sampled from cohorts of male Israeli soldiers aged 18-21 years, serving in field units and followed up for diarrheal diseases. Case patients (n = 177) were subjects who visited the base clinic because diarrhea and were positive for Shigella sonnei (n = 66), enterotoxigenic Escherichia coli (ETEC) (n = 31) or negative for bacterial pathogens (n = 80; diarrhea of unknown etiology). Controls (n = 418) were subjects who did not suffer from a diarrheal disease during the follow-up. They were matched to case patients by training unit and period. Serum samples were obtained from participants at the beginning of their field training and were tested for anti-H. pylori immunoglobulin (Ig) G and preexisting Shigella sonnei lipopolysaccharide IgG and IgA antibodies using enzyme-linked immunosorbent assay.
RESULTS: The proportion of H. pylori-infected subjects was significantly lower among case patients with infection of unknown etiology (36.3%) than among controls (56.0%) (adjusted odds ratio [OR], 0.43; 95% confidence interval [CI], .24-.77; P = .005). The proportion of H. pylori-infected subjects among case patients with S. sonnei shigellosis was also significantly lower than in the control group: 36.3% versus 56.0%. The association persisted after adjusting for sociodemographic variables and preexisting S. sonnei serum IgA antibodies (adjusted OR, 0.37; 95% CI, .14-.95; P = .03) and IgG antibodies (adjusted OR, 0.38; 95% CI, .14-.99; P = .04). The direction of the association between H. pylori infection and ETEC diarrhea was similar, albeit not statistically significant.
CONCLUSIONS: Our findings suggest an active role of H. pylori in protection against diarrheal diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22157171     DOI: 10.1093/cid/cir916

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

Review 1.  The impoverished gut--a triple burden of diarrhoea, stunting and chronic disease.

Authors:  Richard L Guerrant; Mark D DeBoer; Sean R Moore; Rebecca J Scharf; Aldo A M Lima
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-11       Impact factor: 46.802

Review 2.  Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects.

Authors:  Denisse Bravo; Anilei Hoare; Cristopher Soto; Manuel A Valenzuela; Andrew Fg Quest
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

3.  Gastric Helicobacter pylori Infection Affects Local and Distant Microbial Populations and Host Responses.

Authors:  Sabine Kienesberger; Laura M Cox; Alexandra Livanos; Xue-Song Zhang; Jennifer Chung; Guillermo I Perez-Perez; Gregor Gorkiewicz; Ellen L Zechner; Martin J Blaser
Journal:  Cell Rep       Date:  2016-02-04       Impact factor: 9.423

Review 4.  Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism-mutualism continuum.

Authors:  Derek Lin; Britt Koskella
Journal:  Evol Appl       Date:  2014-11-20       Impact factor: 5.183

5.  Silane Modified Diopside for Improved Interfacial Adhesion and Bioactivity of Composite Scaffolds.

Authors:  Cijun Shuai; Chenying Shuai; Pei Feng; Youwen Yang; Yong Xu; Tian Qin; Sheng Yang; Chengde Gao; Shuping Peng
Journal:  Molecules       Date:  2017-03-23       Impact factor: 4.411

6.  Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults.

Authors:  Khitam Muhsen; Samba O Sow; Milagritos D Tapia; Fadima C Haidara; Mardi Reymann; Valeria Asato; Wilbur H Chen; Marcela F Pasetti; Myron M Levine
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

7.  Serologic host response to Helicobacter pylori and Campylobacter jejuni in socially housed Rhesus macaques (Macaca mulatta).

Authors:  Sabine Kienesberger; Guillermo I Perez-Perez; Juan L Rivera-Correa; Rafael Tosado-Acevedo; Huilin Li; Andre Dubois; Janis A Gonzalez-Martinez; Maria Gloria Dominguez-Bello; Martin J Blaser
Journal:  Gut Pathog       Date:  2012-08-24       Impact factor: 4.181

Review 8.  Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis.

Authors:  Sanjin Alajbegovic; John W Sanders; Deborah E Atherly; Mark S Riddle
Journal:  Syst Rev       Date:  2012-08-28

9.  Helicobacter pylori Infection Aggravates Dysbiosis of Gut Microbiome in Children With Gastritis.

Authors:  Lu Yang; Jiaming Zhang; Junjie Xu; Xuxia Wei; Junjie Yang; Yi Liu; Hua Li; Changying Zhao; Ying Wang; Lei Zhang; Zhongtao Gai
Journal:  Front Cell Infect Microbiol       Date:  2019-11-07       Impact factor: 5.293

10.  Determining the association between fibromyalgia, the gut microbiome and its biomarkers: A systematic review.

Authors:  Sharon Erdrich; Jason A Hawrelak; Stephen P Myers; Joanna E Harnett
Journal:  BMC Musculoskelet Disord       Date:  2020-03-20       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.